Pharming Group (PHAR)
9.30
-0.25
(-2.62%)
USD |
NASDAQ |
May 17, 16:00
Pharming Group Free Cash Flow: -3.493M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -3.493M |
| December 31, 2023 | -18.77M |
| September 30, 2023 | -25.09M |
| June 30, 2023 | -15.96M |
| March 31, 2023 | -2.753M |
| December 31, 2022 | 20.48M |
| September 30, 2022 | 25.37M |
| June 30, 2022 | 15.48M |
| March 31, 2022 | 17.26M |
| December 31, 2021 | 21.13M |
| September 30, 2021 | 26.61M |
| June 30, 2021 | 41.66M |
| March 31, 2021 | 57.62M |
| December 31, 2020 | 68.33M |
| September 30, 2020 | 72.20M |
| June 30, 2020 | 58.12M |
| March 31, 2020 | 52.87M |
| December 31, 2019 | 48.70M |
| September 30, 2019 | 45.83M |
| June 30, 2019 | 59.23M |
| March 31, 2019 | 54.92M |
| December 31, 2018 | 42.03M |
| September 30, 2018 | 58.19M |
| June 30, 2018 | 54.47M |
| Date | Value |
|---|---|
| March 31, 2018 | 42.49M |
| December 31, 2017 | 38.59M |
| September 30, 2017 | 8.529M |
| June 30, 2017 | -8.866M |
| March 31, 2017 | -14.67M |
| December 31, 2016 | -12.11M |
| September 30, 2016 | -18.28M |
| June 30, 2016 | -19.16M |
| March 31, 2016 | -18.39M |
| December 31, 2015 | -19.68M |
| September 30, 2015 | -1.682M |
| June 30, 2015 | 0.98M |
| March 31, 2015 | -1.745M |
| December 31, 2014 | -3.129M |
| September 30, 2014 | -7.763M |
| June 30, 2014 | -5.324M |
| March 31, 2014 | -2.762M |
| December 31, 2013 | -0.029M |
| September 30, 2013 | -8.279M |
| June 30, 2013 | -13.03M |
| March 31, 2013 | -13.14M |
| December 31, 2012 | -14.39M |
| September 30, 2012 | -34.95M |
| June 30, 2012 | -33.60M |
Free Cash Flow Range, Past 5 Years
-25.09M
Minimum
Sep 2023
72.20M
Maximum
Sep 2020
28.24M
Average
25.99M
Median
Free Cash Flow Benchmarks
| uniQure NV | -135.36M |
| ProQR Therapeutics NV | -43.28M |
| Merus NV | -150.28M |
| argenx SE | -- |
| Pharvaris NV | -100.10M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.647M |
| Cash from Investing (Quarterly) | 0.664M |
| Cash from Financing (Quarterly) | -2.471M |
| Free Cash Flow Per Share (Quarterly) | -0.1179 |
| Free Cash Flow to Equity (Quarterly) | -4.194M |
| Free Cash Flow to Firm (Quarterly) | -7.727M |
| Free Cash Flow Yield | -0.52% |